October 3-4, 2017 | Philadelphia, PA
www.cbinet.com/OutcomesContracting
Exclusive Offer for Drug Channels Readers:
Register Now to SAVE $400* using promo code DCR400
Register Now to SAVE $400* using promo code DCR400
Hurry! This Offer Expires August 14, 2017.
CBI’s 2nd Annual Life Sciences Outcomes-Based Contracting Summit provides critical strategies into the process of outlining, structuring and negotiating risk-sharing agreements between bio/pharma manufacturers and payers.
This timely event will address the continuous challenges the industry faces to lower drug costs and increase patient access, all while demonstrating the value of their drugs to insurers by providing best practices and key insights from thought-leaders regarding the nuances surrounding outcomes-based contracting.
Join us for Solutions-Oriented Sessions, Powerful Payer Insights and Illuminating Case Studies:
- Gain an understanding of the risk-sharing challenges from the payers perspective, featuring Michael Sherman, MD, Sr. Vice President and Chief Medical Officer of Harvard Pilgrim Health Care
- Bridge the gap between real-world evidence and health economics outcomes research
- Manage legal, compliance and regulatory concerns surrounding value-based contracts
- Examine the benefits and challenges of outcomes-based contracts for target population (orphan/rare disease) therapies
- Translate successful European managed entry agreements into actionable opportunities for the U.S. marketplace
- Discuss the challenges and rewards of co-developing drugs and diagnostics for enhanced outcomes
- And more!
*Discount offer valid through 8/14/17; applies to standard rates only and may not be combined with other offers, category rates, promotions or applied to existing registration. Offer not valid on workshops only or academic/non-profit registration.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.
No comments:
Post a Comment